STERIS plc $STE Shares Sold by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC cut its stake in STERIS plc (NYSE:STE) by 4.9% during the 3rd quarter, HoldingsChannel reports. The fund owned 45,684 shares of the medical equipment provider’s stock after selling 2,356 shares during the period. Segall Bryant & Hamill LLC’s holdings in STERIS were worth $11,304,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Steigerwald Gordon & Koch Inc. bought a new stake in shares of STERIS in the 3rd quarter worth about $25,000. Spurstone Advisory Services LLC bought a new position in shares of STERIS during the second quarter worth about $29,000. Cloud Capital Management LLC acquired a new position in STERIS in the third quarter worth about $29,000. Geneos Wealth Management Inc. increased its holdings in STERIS by 416.0% in the first quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 104 shares during the last quarter. Finally, TruNorth Capital Management LLC acquired a new stake in STERIS during the third quarter valued at approximately $37,000. 94.69% of the stock is currently owned by institutional investors.

STERIS Stock Up 0.0%

NYSE:STE opened at $243.37 on Thursday. The company has a current ratio of 2.48, a quick ratio of 1.75 and a debt-to-equity ratio of 0.26. The stock has a 50 day moving average of $255.21 and a 200-day moving average of $251.70. The firm has a market capitalization of $23.87 billion, a PE ratio of 33.94 and a beta of 1.05. STERIS plc has a 52 week low of $204.90 and a 52 week high of $269.44.

STERIS (NYSE:STE) last released its quarterly earnings data on Wednesday, February 4th. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $2.53. STERIS had a return on equity of 14.34% and a net margin of 12.15%.During the same quarter last year, the company posted $2.32 earnings per share. The firm’s revenue was up 9.2% on a year-over-year basis. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. Analysts predict that STERIS plc will post 9.08 EPS for the current year.

STERIS Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Tuesday, February 17th will be given a dividend of $0.63 per share. The ex-dividend date is Tuesday, February 17th. This represents a $2.52 annualized dividend and a dividend yield of 1.0%. STERIS’s dividend payout ratio is currently 35.15%.

Wall Street Analyst Weigh In

A number of research firms have commented on STE. Weiss Ratings reaffirmed a “buy (b)” rating on shares of STERIS in a report on Friday, January 9th. Wall Street Zen cut STERIS from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 14th. Six equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, STERIS presently has a consensus rating of “Moderate Buy” and a consensus price target of $275.20.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.